TCL Archive Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation November 17, 2006
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting April 29, 2011
TCL Archive DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan June 10, 1988
TCL Archive Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin July 23, 2010
